Johnson & Johnson (NY:JNJ)

Equities rallied as the theme of bad news is good news is back; investors now wait for the latest read on inflation and its impact on holiday spending

Topics Stocks

MarketBeat Week in Review – 10/30 - 11/3

November 04, 2023

EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END

Topics Economy

Get Ready for Next Generation of Diabetes, Weight-Management Drugs

November 01, 2023

Via Investor Brand Network

Get Ready for Next Generation of Diabetes, Weight-Management Drugs

November 01, 2023

Via FinancialNewsMedia

Investor patience tested as pharmaceutical stocks take a tumble

November 01, 2023

The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector

Johnson & Johnson stock fell in the past week as talc-related lawsuits weigh on a subsidiary, which is mulling bankruptcy to mitigate payouts and settlements.

J&J stock down as business unit mulls talc-related bankruptcy

October 31, 2023

Dividend aristocrats Caterpillar, NextEra, and Clorox have shown resilience in challenging times. These may offer opportunities as they are trading off highs.

Topics Bankruptcy Lawsuit

Are These 3 Dividend Aristocrats Undervalued Hidden Gems?

October 25, 2023

Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech

October 23, 2023

MedTech stocks are performing well and supported by pent-up demand, yet share prices are trading at significant and often historical lows.

The Value Deepens for Medtech Stocks: Reversal Imminent

October 23, 2023

Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2023

October 19, 2023

Abbott Laboratories rises on solid results and guidance; the value and dividend are at the best levels in years, and the sell-side is buying.

Oversold and Overextended, Abbott Laboratories is a Great Buy

October 18, 2023

Johnson & Johnson Reports Q3 2023 Results

October 17, 2023

Steroids Market Is Set to Fly High in Years to Come : Pfizer, Johnson & Johnson, Bayer ↗

October 10, 2023

Stay up to date with Steroids Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

3 Undervalued Healthcare Stocks to Watch as Sector Struggles

October 06, 2023

As the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth.

As the market experiences heightened volatility and uncertainty, it's worth exploring defensive stocks like JNJ, PG, and VZ for stability amid the uncertainty.

3 Blue Chip Safe Havens to Shield Your Portfolio

September 25, 2023

Shares of SharkNinja, Inc. are up more than 50% since August 4th — and becoming a popular momentum bet amongst retail traders.

Topics ETFs Economy

3 Reasons SharkNinja Is Swimming Toward New Highs

September 22, 2023

In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends.

Flee to Healthcare Stocks if Recession Rears its Head?

September 20, 2023

EQNX::TICKER_START (NYSE:JNJ),(NYSE:ABBV),(NASDAQ:ATAI),(NASDAQ:CMPS),(NASDAQ:MNMD) EQNX::TICKER_END

Topics Economy

The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis

September 19, 2023

Via FinancialNewsMedia

Topics Economy

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

September 18, 2023

Johnson & Johnson Marks New Era as Global Healthcare Company With Updated Visual Identity

September 14, 2023

Dividend Growth Rates and How to Calculate Them

September 08, 2023

Blue-chip stocks are the stocks of well-known, high-quality industry leaders. Learn more about our top picks for the best blue chip stocks to buy now.

7 Best Blue Chip Stocks to Buy Now

September 08, 2023

EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END

Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030

September 08, 2023

Via FinancialNewsMedia

3 Stocks Awaiting Winter Winds of Opportunity

September 07, 2023

The change in seasons favors specific stocks like JNJ, GOOS, and MTN, which exhibit growth patterns tied to seasonal changes.

Newly public company Kenvue, a spinoff from Johnson & Johnson, joins the ranks of dividend aristocrats, offering a 3.57% yield, and 2022 sales of $15 billion.

J&J Spinoff Kenvue is the New Dividend Aristocrat on the Block

September 07, 2023

Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.

Topics ETFs

How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?

September 01, 2023

Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation

Topics Economy

August 30, 2023

Heavy short interest can be a sell signal, but these three stocks have bullish stories that make them attractive investments despite heavy short interest

3 High Short Interest Stocks that Investors are Getting Wrong

August 25, 2023

Disney is facing decisions about a potential split, with a focus on core businesses like streaming, parks, and film studios. CEO Bob Iger remains noncommittal.

Disney's Big Breakup? Wall Street, Iger Ponder A Magical Split

August 23, 2023

Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc.

Topics Earnings

August 23, 2023